Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CRNX | ALPN | SMMT | ||
Company | Crinetics Pharmaceuticals Inc | Alpine Immune Sciences Inc | Summit Therapeu ADR | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 45.61 | 64.62 | 4.68 | ||
High | 46.96 | 64.68 | 4.68 | ||
Low | 44.84 | 64.58 | 3.95 | ||
Last | 46.78 | 64.60 | 4.06 | ||
Change | +1.73 | unch | -0.64 | ||
% Change | +3.84% | unch | -13.62% | ||
Volume | 609,200 | 2,816,700 | 3,013,600 | ||
20-Day Average Volume | 630,885 | 4,468,280 | 1,851,915 | ||
Previous Close | 45.05 | 64.60 | 4.70 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 44.58 | 59.60 | 3.81 | ||
20-Day Raw Stochastic | 74.61% | 99.61% | 43.64% | ||
20-Day Relative Strength | 58.11% | 80.37% | 52.17% | ||
Weighted Alpha | +45.57 | +305.12 | +111.97 | ||
Today's Opinion | 96% Buy | 100% Buy | 80% Buy | ||
Previous Opinion | 88% Buy | 100% Buy | 80% Buy | ||
Last Month's Opinion | 100% Buy | 100% Buy | 40% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +10.62% since 04/25/24 | -0.03% since 04/25/24 | +14.37% since 04/25/24 | ||
Low | 41.59 on 04/29/24 | 64.51 on 04/26/24 | 3.52 on 04/26/24 | ||
High | 46.96 on 05/02/24 | 64.72 on 04/30/24 | 4.99 on 05/01/24 | ||
1-Month | |||||
%Chg | +1.70% since 04/02/24 | +64.75% since 04/02/24 | +5.45% since 04/02/24 | ||
Low | 41.05 on 04/25/24 | 34.25 on 04/08/24 | 3.34 on 04/19/24 | ||
High | 49.58 on 04/04/24 | 64.72 on 04/30/24 | 4.99 on 05/01/24 | ||
3-Month | |||||
%Chg | +26.16% since 02/02/24 | +133.30% since 02/02/24 | +4.64% since 02/02/24 | ||
Low | 35.79 on 02/14/24 | 26.09 on 02/07/24 | 3.25 on 03/22/24 | ||
High | 49.58 on 04/04/24 | 64.72 on 04/30/24 | 5.22 on 03/05/24 | ||
6-Month | |||||
%Chg | +60.21% since 11/02/23 | +338.86% since 11/02/23 | +103.00% since 11/02/23 | ||
Low | 25.75 on 11/10/23 | 10.80 on 11/13/23 | 1.64 on 11/09/23 | ||
High | 49.58 on 04/04/24 | 64.72 on 04/30/24 | 5.22 on 03/05/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 3,547,417 | 4,235,176 | 3,299,282 | ||
Shares Outstanding, K | 78,744 | 65,560 | 701,975 | ||
Annual Sales | 4,010,000 | 58,880,000 | 0 | ||
Annual Net Income | -214,530,000 | -32,180,000 | -614,930,000 | ||
Last Quarter Sales | 350,000 | 30,850,000 | 0 | ||
Last Quarter Net Income | -57,460,000 | 5,960,000 | -36,570,000 | ||
60-Month Beta | 0.63 | 0.96 | -1.13 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.90 on 02/28/24 | 0.15 on 03/18/24 | -0.04 on 02/20/24 | ||
Latest Earnings Date | 05/02/24 | 05/09/24 | 05/01/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |